BURNING ROCK BIOTECH LTD
NASDAQ: BNR (Burning Rock Biotech Limited)
Kemas kini terakhir: 5 jam lalu13.24
-0.08 (-0.60%)
| Penutupan Terdahulu | 13.32 |
| Jumlah Dagangan | 27,870 |
| Purata Dagangan (3B) | 36,148 |
| Modal Pasaran | 139,633,584 |
| Harga / Jualan (P/S) | 1.91 |
| Harga / Buku (P/B) | 1.84 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Jun 2025 - 6 Jun 2025 |
| Margin Keuntungan | -13.59% |
| Margin Operasi (TTM) | -12.99% |
| EPS Cair (TTM) | -0.800 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -9.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 9.08% |
| Nisbah Semasa (MRQ) | 3.05 |
| Aliran Tunai Operasi (OCF TTM) | -12.22 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 12.98 M |
| Pulangan Atas Aset (ROA TTM) | -5.16% |
| Pulangan Atas Ekuiti (ROE TTM) | -12.82% |
AISkor Stockmoo
| Nilai 30% | 0.0 |
| Hutang rendah. Keuntungan lemah. Kecairan jangka pendek mencukupi. Aliran tunai positif. info | |
| Daripada penilaian laporan AI Insight kami tentang pulangan dijangka berbanding risiko. info | NA |
| Penilaian Relatif info | NA |
| Pertumbuhan Tersirat info | NA |
| Sejarah Penilaian info | NA |
| Pulangan atas Modal info | NA |
| Nilai Pegangan info | NA |
| Premium Risiko info | NA |
| Penilaian Pasaran info | NA |
| Masa 30% | -2.5 |
| Tiada aliran jelas sepanjang tahun lalu. Jauh di bawah paras tertinggi 52 minggu. info | |
| Tiada aliran jelas: harga bergerak di sekitar purata bergeraknya. Harga hampir dengan purata itu. Dagangan lebih tinggi pada hari harga naik. info | |
| Daripada analisis teknikal AI kami terhadap carta. info | NA |
| Corak Lilin info | NA |
| Sentimen 20% | 0.0 |
| Tiada harga sasaran terkini, jadi berdasarkan arah semakan harga sasaran. info | |
| Sentimen Pegangan info | NA |
| Sentimen Berita info | NA |
| Wang Pintar 20% | -0.1 |
| Institusi bersih -0.14% daripada saham dalam pemfailan 13F terkini: 7 pemegang menambah, 10 mengurang (suku berakhir 30 Sep 2026). info | |
| Kedudukan jual singkat -10.1% dari 31 Aug hingga 30 Oct 2026, 1.3 hari untuk tutup (FINRA). info | |
| Aktiviti Orang Dalam info | NA |
| Keadaan pasaran dan sektor menggalakkan. | |
| Persekitaran pasaran berhati-hati. info | |
| Sektor mengatasi prestasi pasaran. | |
| Hanya satu tonggak mempunyai bacaan yang jelas, jadi skor tidak berubah. | |
| Tidak dikira dalam skor | |
| Perolehan sesaham turun naik. Mencatat kerugian dalam tahun-tahun kebelakangan. info | |
| Hampir dengan garis aliran jangka sederhana. info | |
| Harga rendah berbanding purata 52 minggunya. Turun dalam tempoh 5 tahun. info | |
| Aliran jangka pendek dan sederhana naik, jangka panjang turun. Momentum jangka pendek meningkat. info | |
| Harga hampir dengan paras rintangan. Paras sokongan dan rintangan menaik. info | |
| Skor Akhir | -0.73 |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | Burning Rock Biotech Limited | - | - |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B | Skor |
|---|---|---|---|---|---|
| BNR | 140 M | - | - | 1.84 | -0.7 |
| ADVB | - | - | - | 0.280 | -2.3 |
| GH | 20 B | - | - | - | -0.6 |
| MEDP | 18 B | - | 35.20 | 31.23 | 1.2 |
| IDXX | - | - | - | 29.54 | 0.0 |
| ILMN | - | - | - | 9.79 | -0.2 |
|
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| % Dimiliki oleh Orang Dalam | 4.03% |
| % Dimiliki oleh Institusi | 47.06% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Redwood Wealth Management Group, Llc | 31 Mar 2026 | 18,278 |
| Almanack Investment Partners, Llc. | 30 Sep 2026 | 15,573 |
Tiada data dalam julat masa ini.
Institusi
Pemilikan institusi: 1.94%
| Kedudukan | Pemegang | Saham |
|---|---|---|
| Bertambah | 7 | 73,238 |
| Berkurang | 10 | 116,534 |
| Baharu | 5 | 19,687 |
| Dijual habis | 5 | 101,599 |
Pemfailan SEC 13F melalui Nasdaq, pemfailan terkini hingga 30 Sep 2026. Pemfailan tiba sehingga 45 hari selepas setiap suku.
Kedudukan Jual Singkat
| Penyelesaian | Saham | Hari untuk tutup |
|---|---|---|
| 30 Oct 2026 | 34,334 | 1.3 |
| 15 Oct 2026 | 36,898 | 1.5 |
| 30 Sep 2026 | 41,425 | 1.0 |
| 15 Sep 2026 | 39,415 | 1.0 |
| 31 Aug 2026 | 38,178 | 5.0 |
| 14 Aug 2026 | 39,450 | 5.2 |
Data jual singkat FINRA melalui Nasdaq, dilaporkan dua kali sebulan.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 17 Nov 2026 | Yahoo Finance |
Burning Rock Announces 2026 Annual General Meeting to be Held on December 22, 2026
GUANGZHOU, China, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that it will hold its annual… |
| 10 Sep 2026 | Yahoo Finance |
Burning Rock Reports Second Quarter 2026 Financial Results
GUANGZHOU, China, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next-generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three… |
Isyarat Terkini corak lilin dan silang EMA
Persediaan Teknikal Sederhana
AI Analisis Teknikal
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |